SCHEMBL26522667

SCHEMBL26522667

Cc1cnn(-c2cccc(N)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.44
KDM4E B2RXH2 3/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NOS3 P29474 1/20 0.42
NOS2 P35228 1/20 0.42
ALDH1A1 P00352 5/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HSD17B10 Q99714 2/20 0.39
IRAK4 Q9NWZ3 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ATM Q13315 1/20 0.37
CYP1A2 P05177 3/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895758 0.87 KDM4E (0.49) TDO2KDM4EMAPTL3MBTL1MAPK1
SCHEMBL2005694 0.82 MAPT (0.45) TDO2KDM4EMAPTL3MBTL1MAPK1
SCHEMBL16547474 0.77 ALDH1A1 (0.48) TDO2KDM4EMAPTL3MBTL1MAPK1
SCHEMBL24135536 0.77 GRIN2D (0.35) MAPTNOS3NOS2NPC1RAB9A
SCHEMBL20574129 0.76 GRIN2D (0.34) KDM4EMAPK1NOS3NOS2ALDH1A1
SCHEMBL27136755 0.76 ALDH1A1 (0.47) KDM4EMAPTL3MBTL1MAPK1NPSR1
SCHEMBL15330702 0.76 ALDH1A1 (0.41) TDO2KDM4EMAPTL3MBTL1MAPK1
SCHEMBL30444751 0.76 GRIN2D (0.34) KDM4EMAPK1NOS3NOS2ALDH1A1
SCHEMBL15293912 0.74 KDM4E (0.42) TDO2KDM4EMAPTL3MBTL1MAPK1
SCHEMBL3149078 0.71 ALKBH2 (0.57) TDO2KDM4EMAPTL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072301-A1 PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE COMPOUND AND MEDICAL USE THEREOF 正大天晴药业集团股份有限公司 2023-05-04 WO disclosed